Macitentan superior to bosentan in pulmonary arterial hypertension due to congenital heart disease?

被引：0
|
作者：
Blok, I. M. [1 ]
Van Riel, A. C. M. J. [1 ]
Schuuring, M. J. [1 ]
De Bruin-Bon, R. H. A. C. M. [1 ]
Van Dijk, A. P. J. [2 ]
Zwinderman, A. H. [1 ]
Mulder, B. J. M. [1 ]
Bouma, B. J. [1 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, Cardiol, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Nijmegen Hosp, Cardiol, NL-6500 HB Nijmegen, Netherlands
来源：
EUROPEAN HEART JOURNAL | 2015年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P2658
引用
收藏
页码：458 / 458
页数：1
相关论文
共 50 条
  • [1] From bosentan to macitentan for pulmonary arterial hypertension and adult congenital heart disease: Further improvement?
    Blok, Ilja M.
    van Riel, Annelieke C. M. J.
    van Dijk, Arie P. J.
    Mulder, Barbara J. M.
    Bouma, Berto J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 227 : 51 - 52
  • [2] Early Experience of Macitentan for Pulmonary Arterial Hypertension in Adult Congenital Heart Disease
    Herbert, S.
    Gin-Sing, W.
    Howard, L.
    Tulloh, R. M. R.
    HEART LUNG AND CIRCULATION, 2017, 26 (10): : 1113 - 1116
  • [3] Macitentan in Pulmonary Arterial Hypertension Associated with Congenital Heart Defects
    Wacker, Julie
    Weintraub, Robert G.
    HEART LUNG AND CIRCULATION, 2017, 26 (10): : 1006 - 1007
  • [4] Effect of bosentan in children with pulmonary arterial hypertension associated with congenital heart disease
    Rosenzweig, E. Berman
    Ivy, D. D.
    Doran, A. K.
    Claussen, L. R.
    Yung, D.
    Widlitz, A. C.
    Abman, S.
    Barst, R. J.
    EUROPEAN HEART JOURNAL, 2006, 27 : 617 - 617
  • [5] Efficacy and Safety of Bosentan for Pulmonary Arterial Hypertension in Adults With Congenital Heart Disease
    Monfredi, Oliver
    Griffiths, Linda
    Clarke, Bernard
    Mahadevan, Vaikom S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (10): : 1483 - 1488
  • [6] Pulmonary arterial hypertension treatment with bosentan in pediatric patients with congenital heart disease
    Romero Jimenez, Rosa M.
    Garcia Sanchez, Raquel
    Gimenez Manzorro, Alvaro
    Martinez Fernandez-Llamazares, Cecilia
    Sanjurjo Saez, Maria
    PHARMACY WORLD & SCIENCE, 2009, 31 (02): : 347 - 347
  • [7] Adult patients with pulmonary arterial hypertension due to congenital heart disease: a review on advanced medical treatment with bosentan
    Schuuring, Mark J.
    Vis, Jeroen C.
    Duffels, Marielle G.
    Bouma, Berto J.
    Mulder, Barbara J. M.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 : 359 - 366
  • [8] Switch From Bosentan to Macitentan in Patients With Pulmonary Arterial Hypertension
    Gray, Carol
    Jones, Sharon
    Stewart, Jeffrey
    CHEST, 2015, 148 (04)
  • [9] Tolerability of Switch to Macitentan from Bosentan in Pulmonary Arterial Hypertension
    Safdar, Zeenat
    Thakur, Aishwarya
    Frost, Adaani
    SOUTHERN MEDICAL JOURNAL, 2017, 110 (03) : 223 - 228
  • [10] Bosentan in pulmonary arterial hypertension: a comparison between congenital heart disease and chronic pulmonary embolism
    M. G. J. Duffels
    M. N. van der Plas
    S. Surie
    M. M. Winter
    B. J. Bouma
    M. Groenink
    A. P. J. van Dijk
    E. S. Hoendermis
    R. M. F. Berger
    P. Bresser
    B. J. M. Mulder
    Netherlands Heart Journal, 2009, 17 : 334 - 338
12345